Bioactive Small Molecules: Promising Novel Therapies in Cardiovascular Diseases – PART I

Author(s): Yu Yu.

Journal Name: Current Topics in Medicinal Chemistry

Volume 19 , Issue 20 , 2019

Become EABM
Become Reviewer

[1]
McClellan, M.; Brown, N.; Califf, R.M.; Warner, J.J. Call to action: Urgent challenges in cardiovascular disease: a presidential advisory from the american heart association. Circulation, 2019, 139(9), e44-e54.
[2]
Chen, B.; Zhao, P.J.; Shi, X.; Cui, Y.P.; Hou, A.P. A review of PCSK9 inhibitors and their effects on cardiovascular disease. Curr. Top. Med. Chem., 2019, 19(20), 1790-1817.
[3]
Liu, B.; Wang, Y.L.; Zhang, Y.Y.; Yan, B. Mechanisms of protective effects of SGLT2 inhibitors in cardiovascular disease and renal dysfunction. Curr. Top. Med. Chem., 2019, 19(20), 1818-1849.
[4]
Fu, S.H.; Chang, Z.Y.; Luo, L.M.; Deng, J.L. Therapeutic progress and knowledge basis about natriuretic peptide system in heart failure. Curr. Top. Med. Chem., 2019, 19(20), 1850-1866.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 19
ISSUE: 20
Year: 2019
Page: [1789 - 1789]
Pages: 1
DOI: 10.2174/156802661920191023163038

Article Metrics

PDF: 14
HTML: 3